NO971038L - Pyrimido£5,4-d|pyrimidiner, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling av dem - Google Patents
Pyrimido£5,4-d|pyrimidiner, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling av demInfo
- Publication number
- NO971038L NO971038L NO971038A NO971038A NO971038L NO 971038 L NO971038 L NO 971038L NO 971038 A NO971038 A NO 971038A NO 971038 A NO971038 A NO 971038A NO 971038 L NO971038 L NO 971038L
- Authority
- NO
- Norway
- Prior art keywords
- pyrimido
- pyrimidines
- compounds
- preparation
- drugs containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- JOZPEVMCAKXSEY-UHFFFAOYSA-N pyrimido[5,4-d]pyrimidine Chemical class N1=CN=CC2=NC=NC=C21 JOZPEVMCAKXSEY-UHFFFAOYSA-N 0.000 abstract 1
- 230000019491 signal transduction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Detergent Compositions (AREA)
- Cosmetics (AREA)
- Luminescent Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4431867A DE4431867A1 (de) | 1994-09-07 | 1994-09-07 | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE1995103151 DE19503151A1 (de) | 1995-02-01 | 1995-02-01 | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE1995121386 DE19521386A1 (de) | 1995-02-01 | 1995-06-13 | Pyrimido/5,4-d/pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE1995128672 DE19528672A1 (de) | 1995-02-01 | 1995-08-04 | Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| PCT/EP1995/003482 WO1996007657A1 (de) | 1994-09-07 | 1995-09-05 | Pyrimido[5,4-d]pyrimidine, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971038D0 NO971038D0 (no) | 1997-03-06 |
| NO971038L true NO971038L (no) | 1997-05-06 |
| NO307833B1 NO307833B1 (no) | 2000-06-05 |
Family
ID=27436041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971038A NO307833B1 (no) | 1994-09-07 | 1997-03-06 | Pyrimido[5,4-d]pyrimidiner, fysiologisk aksepterbare salter, legemidler inneholdende disse forbindelser og deres anvendelse |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5707989A (no) |
| EP (1) | EP0779888B1 (no) |
| JP (1) | JP3184533B2 (no) |
| CN (1) | CN1047778C (no) |
| AT (1) | ATE179420T1 (no) |
| AU (1) | AU688972B2 (no) |
| BG (1) | BG62969B1 (no) |
| CA (1) | CA2199401C (no) |
| CZ (1) | CZ295781B6 (no) |
| DE (1) | DE59505789D1 (no) |
| DK (1) | DK0779888T3 (no) |
| EE (1) | EE9700211A (no) |
| ES (1) | ES2133800T3 (no) |
| FI (1) | FI112947B (no) |
| GR (1) | GR3030589T3 (no) |
| HK (1) | HK1000837A1 (no) |
| HU (1) | HUT77744A (no) |
| IL (1) | IL115185A0 (no) |
| MX (1) | MX9701662A (no) |
| NO (1) | NO307833B1 (no) |
| NZ (1) | NZ292909A (no) |
| PL (1) | PL319042A1 (no) |
| RO (1) | RO120342B1 (no) |
| SK (1) | SK284277B6 (no) |
| TW (1) | TW414798B (no) |
| WO (1) | WO1996007657A1 (no) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| TW321649B (no) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| GB9424233D0 (en) * | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| DE69613367T2 (de) * | 1995-04-27 | 2002-04-18 | Astrazeneca Ab | Chinazolin derivate |
| GB9508537D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9508535D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
| GB9508565D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| SK285141B6 (sk) | 1996-02-13 | 2006-07-07 | Astrazeneca Uk Limited | Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| GB9603097D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline compounds |
| EP0885198B1 (en) | 1996-03-05 | 2001-12-19 | AstraZeneca AB | 4-anilinoquinazoline derivatives |
| DE19608653A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE19608588A1 (de) * | 1996-03-06 | 1997-09-11 | Thomae Gmbh Dr K | Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| DE19613691A1 (de) | 1996-04-05 | 1997-10-09 | Boehringer Ingelheim Int | Arzneimittel für die Behandlung von Tumorerkrankungen |
| EP0892789B2 (en) | 1996-04-12 | 2009-11-18 | Warner-Lambert Company LLC | Irreversible inhibitors of tyrosine kinases |
| GB9607729D0 (en) * | 1996-04-13 | 1996-06-19 | Zeneca Ltd | Quinazoline derivatives |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| EP0912559B1 (en) | 1996-07-13 | 2002-11-06 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| JP3270834B2 (ja) * | 1999-01-27 | 2002-04-02 | ファイザー・プロダクツ・インク | 抗がん剤として有用なヘテロ芳香族二環式誘導体 |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| ES2306306T3 (es) | 1999-11-05 | 2008-11-01 | Astrazeneca Ab | Nuevos derivados de quinazolina. |
| NZ523987A (en) * | 2000-08-09 | 2004-10-29 | Astrazeneca Ab | Indole, azaindole and indazole derivatives having VEGF inhibiting activity |
| DE10115921A1 (de) * | 2001-03-30 | 2002-10-02 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von 4,6-Diaminopyrimido[5,4-d]pyrimidinen |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| EP1660092A2 (en) * | 2003-07-03 | 2006-05-31 | Myriad Genetics, Inc. | 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| UA83881C2 (en) | 2003-12-18 | 2008-08-26 | Янссен Фармацевтика Н.В. | Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP1976840A1 (en) * | 2006-01-13 | 2008-10-08 | F.Hoffmann-La Roche Ag | Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators |
| JP2009542778A (ja) | 2006-07-13 | 2009-12-03 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｍｔｋｉキナゾリン誘導体 |
| DK2185562T3 (en) | 2007-07-27 | 2016-02-22 | Janssen Pharmaceutica Nv | PYRROLOPYRIMIDINES SUITABLE FOR TREATING PROLIFERATIVE DISEASES |
| TW201014860A (en) * | 2008-09-08 | 2010-04-16 | Boehringer Ingelheim Int | New chemical compounds |
| CA2752265A1 (en) | 2009-02-17 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases |
| ES2750598T3 (es) | 2009-09-03 | 2020-03-26 | Bristol Myers Squibb Co | Quinazolinas como inhibidores de los canales iónicos de potasio |
| ES2525837T3 (es) * | 2010-12-01 | 2014-12-30 | Janssen Pharmaceutica, N.V. | Antagonistas de ccr2 de ciclohexilamino-4-piperidinil-acetamida sustituida en posición 4 |
| US20130023531A1 (en) | 2011-01-27 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors |
| WO2012101062A1 (en) | 2011-01-28 | 2012-08-02 | Novartis Ag | Substituted bi-heteroaryl compounds as cdk9 inhibitors and their uses |
| EP2712359B1 (en) | 2011-05-20 | 2017-06-21 | Janssen Pharmaceutica NV | Process for the preparation of compounds useful as inhibitors of sglt-2 |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
| CA2973597A1 (en) | 2015-01-23 | 2016-07-28 | Confluence Life Sciences, Inc. | Heterocyclic itk inhibitors for treating inflammation and cancer |
| WO2019223766A1 (zh) * | 2018-05-25 | 2019-11-28 | 上海和誉生物医药科技有限公司 | 一种fgfr抑制剂、其制备方法和在药学上的应用 |
| US11608343B2 (en) * | 2020-04-24 | 2023-03-21 | Boehringer Ingelheim International Gmbh | Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3031450A (en) * | 1959-04-30 | 1962-04-24 | Thomae Gmbh Dr K | Substituted pyrimido-[5, 4-d]-pyrimidines |
| EP0023559B1 (de) * | 1979-07-03 | 1984-09-19 | Dr. Karl Thomae GmbH | 2-(Perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidine, ihre Herstellung und diese Verbindungen enthaltenden Arzneimittel |
| DE3049207A1 (de) * | 1980-12-27 | 1982-07-29 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel |
| DE3423092A1 (de) * | 1984-06-22 | 1986-01-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| US5034393A (en) * | 1989-07-27 | 1991-07-23 | Dowelanco | Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives |
| DE4325900A1 (de) * | 1993-08-02 | 1995-02-09 | Thomae Gmbh Dr K | Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
-
1995
- 1995-08-31 TW TW084109086A patent/TW414798B/zh not_active IP Right Cessation
- 1995-09-05 JP JP50920696A patent/JP3184533B2/ja not_active Expired - Fee Related
- 1995-09-05 HU HU9800482A patent/HUT77744A/hu not_active Application Discontinuation
- 1995-09-05 CZ CZ1997691A patent/CZ295781B6/cs not_active IP Right Cessation
- 1995-09-05 CN CN95194919A patent/CN1047778C/zh not_active Expired - Fee Related
- 1995-09-05 RO RO97-00401A patent/RO120342B1/ro unknown
- 1995-09-05 NZ NZ292909A patent/NZ292909A/en unknown
- 1995-09-05 PL PL95319042A patent/PL319042A1/xx unknown
- 1995-09-05 WO PCT/EP1995/003482 patent/WO1996007657A1/de active IP Right Grant
- 1995-09-05 ES ES95931988T patent/ES2133800T3/es not_active Expired - Lifetime
- 1995-09-05 MX MX9701662A patent/MX9701662A/es not_active IP Right Cessation
- 1995-09-05 EP EP95931988A patent/EP0779888B1/de not_active Expired - Lifetime
- 1995-09-05 SK SK302-97A patent/SK284277B6/sk unknown
- 1995-09-05 CA CA002199401A patent/CA2199401C/en not_active Expired - Fee Related
- 1995-09-05 DE DE59505789T patent/DE59505789D1/de not_active Expired - Lifetime
- 1995-09-05 AU AU35218/95A patent/AU688972B2/en not_active Ceased
- 1995-09-05 AT AT95931988T patent/ATE179420T1/de active
- 1995-09-05 DK DK95931988T patent/DK0779888T3/da active
- 1995-09-05 EE EE9700211A patent/EE9700211A/xx unknown
- 1995-09-06 IL IL11518595A patent/IL115185A0/xx unknown
- 1995-09-07 US US08/524,707 patent/US5707989A/en not_active Expired - Lifetime
-
1997
- 1997-03-06 BG BG101289A patent/BG62969B1/bg unknown
- 1997-03-06 NO NO971038A patent/NO307833B1/no not_active IP Right Cessation
- 1997-03-07 FI FI970968A patent/FI112947B/fi active
- 1997-12-17 HK HK97102471A patent/HK1000837A1/xx not_active IP Right Cessation
-
1999
- 1999-06-23 GR GR990401672T patent/GR3030589T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971038L (no) | Pyrimido£5,4-d|pyrimidiner, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling av dem | |
| MX9807073A (es) | Pirmido[5,4-d]pirimidinas, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion. | |
| NO984081L (no) | Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremtilling derav | |
| AP9901435A0 (en) | Bicycle heteroaromatic compounds as protein tyrosine kinase inhibitors. | |
| MY123642A (en) | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, and processes for preparing them. | |
| YU90901A (sh) | Biciklični heterocikli, lekovi koji sadrže ta jedinjenja, njihova primena i postupci za njihovo pripremanje | |
| NO984084L (no) | 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav | |
| DK0836605T3 (da) | Pyrrolopyrimidiner og fremgangsmåder til deres fremstilling | |
| YU14003A (sh) | Biciklična heterociklična jedinjenja, lekovi koji sadrže ova jedinjenja, njihova primena i postupak za njihovo dobijanje | |
| EA200701302A1 (ru) | 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы | |
| MY136086A (en) | Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
| TR200102505T2 (tr) | 4-amino-kinazolin ve kinolin türevleri. | |
| DK0888353T3 (da) | N-7-Heterocyclyl-pyrrolo[2,3-d]pyrimidiner og deres anvendelse | |
| AU2001295482A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
| SE9904129D0 (sv) | Novel compounds | |
| GR3003452T3 (en) | Indolocarbazole derivatives, processes for their preparation and their use as medicaments | |
| EA199800192A1 (ru) | Применение ингибиторов фосфодиестеразы (pde) в производстве лекарственных препаратов для лечения заболеваний мочевого пузыря | |
| MY140484A (en) | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them | |
| EA200100830A1 (ru) | Производные 4-аминохиназолина и хинолина, оказывающие ингибирующее действие на преобразование сигнала, опосредованное тирозинкиназой |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |